Christopher Yea, Chief Development Officer: KalVista Pharmaceuticals KALV Sell · Filed 25/05/23

Trade details

Type: Insider sale
Amount: $27,525.96
Shares · price: 2,317 sh · $11.88 a share
Held after: 96,990 sh
Stock: KalVista Pharmaceuticals KALV
Person: Christopher YeaChief Development Officer
Trade date: 25/05/22
Filed: 25/05/23
Days to filing: 1 days

Sold 2.3% of holdings

Share of holding sold: 2.3%

KalVista Pharmaceuticals trades, last 26 weeks

What else happened in KalVista Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/04/22~25/06/21

Christopher Yea's recent trades

Christopher YeaChief Development Officer
SellKalVista Pharmaceuticals
Sell
KalVista Pharmaceuticals
KALV
$905.2K
33,800 sh
$905.2K
Filed 05/29
Traded 05/27
Christopher YeaChief Development Officer
SellKalVista Pharmaceuticals
Sell
KalVista Pharmaceuticals
KALV
$52.6K
1,966 sh
$52.6K
Filed 05/27
Traded 05/26
Christopher YeaChief Development Officer
SellKalVista Pharmaceuticals
Sell
KalVista Pharmaceuticals
KALV
$63.1K
2,358 sh
$63.1K
Filed 05/26
Traded 05/22
Christopher YeaChief Development Officer
SellKalVista Pharmaceuticals
Sell
KalVista Pharmaceuticals
KALV
$29.7K
1,108 sh
$29.7K
Filed 05/19
Traded 05/18
Christopher YeaChief Development Officer
SellKalVista Pharmaceuticals
Sell
KalVista Pharmaceuticals
KALV
$67.7K
4,347 sh
$67.7K
Filed 02/24
Traded 02/23